Industry & Business

Diaceutics to Use Artificial Intelligence to Improve Diagnosis and Treatment of Patients

 Breaking News
  • OPW Prepared For No Deal Brexit “If there is a ‘crash-out’, we will be ready. We are working 24/7,” said Maurice Buckley (pictured), Chairman of the Office of Public Works (OPW) and Vice President of Engineers Ireland, about preparations for installing infrastructure at ports and airports in the event of a ‘no deal Brexit’. “Eighteen separate construction projects are now underway [...]...
  • Irish Builders Face Cost Hikes in UK Materials The vast majority of building materials used in the Irish construction sector are either sourced in the UK or enter Ireland through international distributors in Britain and represent a major risk for the industry, according to executives at the recent National Construction Summit in Citywest, Dublin – writes John Whelan (pictured above). And a huge majority of [...]...
  • Marketing Campaign Worth €1.2 Million Unveiled by Guaranteed Irish Guaranteed Irish, the not-for-profit business membership organisation championing 600+ homegrown and international businesses in Ireland, has unveiled a new marketing campaign worth €1.2 million, aimed at showcasing its members’ success. The campaign has been launched to coincide with Guaranteed Irish Month, an annual event running throughout March that shines a spotlight on businesses in Ireland [...]...
  • Jameson Enters the Top 10 Premium Spirits Brands in the World List Jameson Irish whiskey, which is produced by Irish Distillers at Midleton Distillery in Cork, has entered the top 10 of IMPACT magazine’s annual ‘Top 100 Premium Spirits Brands Worldwide’ list for the first time ever, after increasing sales 10% to a record 7.5 million nine-litre cases in 2018. In addition, Jameson scored its 18th consecutive year [...]...
  • Growth in Demand For Waste Handling Equipment Expected Sales of waste handling and processing equipment are conservatively expected to increase by 5% to 10% annually in unit terms over the next decade, and possibly beyond, according to a study being conducted by leading Birdhill and Rathcoole-based plant and equipment distributor, McHale Plant Sales. Conscious of the growing importance of waste management, and of the [...]...

Diaceutics to Use Artificial Intelligence to Improve Diagnosis and Treatment of Patients

Diaceutics to Use Artificial Intelligence to Improve Diagnosis and Treatment of Patients
March 07
09:26 2018

Diaceutics, the Irish company helping patients to receive potentially lifesaving medicine through better diagnostic testing, has announced a collaboration with computer hardware manufacturer Lenovo, and chip manufacturer Intel. The collaboration will enable Diaceutics to leverage their vast proprietary database of patient testing data in a revolutionary way.

Using artificial intelligence (AI) to see whether patients can be grouped according to diagnostic test information, the company is hopeful that this data can help identify ways to improve diagnosis, treatment and outcomes for patients with similar characteristics.

Utilising one of the most powerful workstations on the planet, with the Lenovo ThinkStation P920 powered by Intel Xeon Scalable processors, and a vast amount of complex testing data from hundreds of clinical laboratories, Diaceutics is aiming to get the right medicine to the right individuals at the right time by classifying patient groups and disease patterns.

After a number of biomarkers covering a variety of tumours and cancer types have been inputted, the machine learning system will be able to identify similarities and patterns within the testing data and highlight what is happening among groups of patients. Essentially, the organisation of this information could mean that at-risk patients can be identified, diagnosed and treated much faster.

Considering that an estimated 78,000 cancer patients are not properly tested each year in the United States and therefore are being denied access to potentially lifesaving medication, this collaboration could further transform the area of personalised medicine. Diaceutics has given more than half a million patients the best possible chance of getting to better treatment through better testing.  The findings from the collaboration will be presented at a series of upcoming conferences.

Peter Keeling (pictured), chief executive officer of Diaceutics, said: “Artificial intelligence can make a very strong and positive impact on precision medicine and we are excited to be moving the boundaries with this highly innovative technology. We can now look at data in a novel way. No longer will we only be  making decisions based on diagnostic data. Artificial intelligence allows us to look at the complete patient journey from initial testing and diagnosis, and on to the ultimate treatment. The result will be significantly better patient testing and likely improved patient outcomes, such as longer cancer survivorship rates.

“This collaboration is a major step in our mission to help patients, by helping them find the right precision medicine at the right time. We are using artificial intelligence to enable the world to unlock the true life changing promise of precision medicine.”

About Author

admin

admin

Related Articles

New Subscriber

Subscribe Here



Advertisements





















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4